1. Home
  2. NYXH

as of 08-20-2026 10:52am EST

$1.66
+$0.01
+0.61%
Stocks Health Care Medical/Dental Instruments Nasdaq

Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.

Founded: 2009 Country:
Belgium
Belgium
Employees: N/A City: N/A
Market Cap: 161.9M IPO Year: 2021
Target Price: $9.33 AVG Volume (30 days): 118.5K
Analyst Decision: Strong Buy Number of Analysts: 3
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: N/A EPS Growth: N/A
52 Week Low/High: $1.26 - $6.87 Next Earning Date: 05-12-2026
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): 213.98% Revenue Growth (next year): 126.25%
P/E Ratio: N/A Index: N/A
Free Cash Flow: N/A FCF Growth: N/A

Share on Social Networks: